Forward Looking Statements

This quarterly report contains forward-looking statements. These statements relate to future events or the Company's future financial performance. In some cases, forward-looking statements can be identified by terminology such as "may", "should", "expects", "plans", "anticipates", "believes", "estimates", "predicts", "potential" or "continue" or negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors" that may cause the Company's or its industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.

The Company's unaudited financial statements are stated in United States Dollars (US$) and are prepared in accordance with United States Generally Accepted Accounting Principles. The following discussion should be read in conjunction with the Company's financial statements and the related notes that appear elsewhere in this quarterly report.

The following discussion contains forward-looking statements that reflect the Company's plans, estimates and beliefs. The Company's actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to such differences include but are not limited to those discussed below and elsewhere in this quarterly report. All adjustments necessary for a fair statement of the results for the interim periods have been made, and all adjustments are of a normal recurring nature.

In this quarterly report, unless otherwise specified, all dollar amounts are expressed in United States Dollars and all references to "common shares" refer to the common shares in the Company's capital stock.

As used in this quarterly report, the terms "we", "us", "our" and "ESSI" mean Eco Science Solutions, Inc. unless otherwise indicated. "Ga-Du" refers to our wholly owned subsidiary Ga-Du Corporation.

Description of Business

The Company was incorporated in the state of Nevada on December 8, 2009 under the name Pristine Solutions, Inc. On February 14, 2014, the Company changed its name to Eco Science Solutions, Inc. ("ESSI")

With headquarters in Maui, Hawaii, Eco Science Solutions, Inc. is a bio and software technology-focused Company targeting the multibillion-dollar health and wellness industry. As consumers continue to take ownership of their health, wellness and alternative medicines they consume, there is a growing shift away from the sole dependence on large pharmaceutical companies and prescription drugs. Thus, in 2020 and beyond, there will be a growing need for both established and new health and wellness businesses to address this increasing demand. In recent years the Company has changed the focus of its original strategy from App based revenue to revenue generated from several key operational areas, including the licensed Herbo Enterprise Software. Herbo is a customizable, all-in-one business software (SaaS) and resource for businesses in the Cannabis and Hemp industries. Herbo provides the software, custom web development, operational training and support needed to plan and manage Marijuana or CBD businesses. The software has provided businesses with intelligence software for over 15 years, while offering seed-to-sale software solutions to the Cannabis and Hemp industries since 2010.

Cultivators, Processors, Manufacturers, Labs, Distributors, Transporters, Dispensaries, Retailers and Regulators, from seed-to-CPA are all target users of Herbo.



                                       5

--------------------------------------------------------------------------------

The Company intends to be a vertically integrated provider of consumer and enterprise technology products and services, which assist consumers, companies, brands and entrepreneurs to effectively transact business, with compliance, in the combined multi-billion-dollar cannabis and CBD hemp industries.

The Company's consumer initiatives are currently centered on education and connecting consumers with various cannabis and CBD hemp businesses. Its enterprise initiatives are focused on developing technology and accounting solutions, coupled with data analytics to help businesses to be more effective in their abilities to connect, market, and sell to consumers.

Over the past several years, ESSI has developed technology and service relationships with those in farming, extraction, manufacturing and distribution in both the cannabis and CBD hemp industries. Along with its subsidiary Ga-Du, ESSI is now able to provide a 360-degree ecosystem for business location, localized communications between consumers and business operators, on-topic social networking, inventory management / selection, payment facilitation and cash management.

* Eco Science Solutions, Inc. is not in the business of growing, manufacturing, or distributing cannabis.

Current business overview

Our business operations commenced generating modest revenues subsequent to our fiscal year ended January 31, 2018 and up to the period ended October 31, 2018, when the initial phase of our eXPOTM beta revenue model testing were complete. Subsequently the operations were suspended through August 2019, during which time AFN solidified its' primary banking relationship and is now able to service and scale as needed with the client's needs. While AFN re-commenced operating the eXPOTM platform during August 2019, Ga-Du does not yet have any additional revenue allocations. Presently AFN is growing exclusively on a Member referral basis. We expect revenue from this agreement to resume during fiscal 2021. During fiscal 2020 we took steps to shift our focus to monetizing our Herbo branded apps and recently developed enterprise software to assist companies in the cannabis industry to simplify their processes, remain compliant, and enjoy steady growth.

During fiscal 2020 the Company and Haiku Holdings LLC ("Haiku"), a company controlled by our CFO and board member, Mr. Mike Rountree, entered into a Trademark Licensing Agreement whereunder our Licensed Marks, including and incorporating Herbo, may be used by Haiku to facilitate business including lead generation and referral services. Subsequently our agreements with Haiku were expanded to include a Software Reseller Agreement with respect to the Herbo suite of enterprise software offerings owned by Haiku. Under the terms of our Reseller agreements with Haiku we commenced generating revenues from licensing of the Herbo software during fiscal 2020 and continue to seek expansion of this growing area of operation during fiscal 2021.

Results of Operations

Comparison of the three months ended July 31, 2020 and 2019:

The following summary of the Company's results of operations should be read in conjunction with the Company's unaudited consolidated financial statements for the three months ended July 31, 2020 and 2019:



                                               For the Three Months
                                                  Ended July 31,
                                                2020           2019
Revenue                                      $   14,730     $        -
Revenue, related parties                          2,697              -
Total revenue                                    17,427              -

Operating expenses:
Cost of revenue                                  13,122              -
Depreciation                                        443          1,105
Legal, accounting and audit fees                 30,131         60,236
Management and consulting fees                   85,000 )      277,000
Research, development, and promotion             36,469              -
Office supplies and other general expenses       45,177         13,130
Advertising and marketing                         1,650         12,146
Total operating expenses                        211,992        363,617

Net operating loss                             (194,565 )     (363,617 )

Other income (expenses)
Interest income                                       -          3,000
Interest expense                                (64,401 )      (62,816 )
Total other income (expense)                    (64,401 )      (59,816 )

Net loss                                     $ (258,966 )   $ (423,433 )




                                       6

--------------------------------------------------------------------------------

Revenue

During the three months ended July 31, 2020, the Company generated $17,427 in total revenue of which $2,697 was from contracts with related parties, as compared to $Nil in the three months ended July 31, 2019. Revenue recorded during the most recently completed three-month period relates directly to the licensing of the Herbo enterprise software to various customers. We entered into amendments to certain licensing and marketing agreements subsequent during fiscal 2019 which provide for fee-based income calculated retroactively between March and October 2018 as a result of certain beta trials with respect to the eXPOTM platform, as at July 31, 2020, the amounts generated from this agreement have not been received by the Company and therefore while revenue has been generated, no revenue has been recorded in our financial statements. We intend to record the revenue attributable to the Company of $28,431 upon receipt.

Cost of Revenue

Costs of revenue consist of the direct expenses incurred to generate revenue, including fees and commissions payable. Such costs are recorded as incurred. During the three months ended July 31, 2020 we incurred costs of $13,122 as compared to $Nil during the three months ended July 31, 2019. Current costs are related to sales of our licensed Herbo enterprise software. Our ongoing costs of revenue will consist consists primarily of fees and commissions paid in respect to the operation and installation of our Herbo enterprise software. In the case of revenue earned by our wholly owned subsidiary, when recorded, proceeds allocated to our revenue interest are net of associated costs.

General and Administrative Expenses



                                               For the three Months
                                                  Ended July 31,
                                                2020           2019        Variances
Operating expenses:
Cost of revenue                              $    13,122     $       -     $   13,122
Depreciation                                         443         1,105           (662 )
Legal, accounting and audit fees                  30,131        60,236        (30,105 )
Management and consulting fees                    85,000       277,000       (192,000 )
Research, development, and promotion              36,469             -         36,469
Office supplies and other general expenses        45,177        13,130        (32,047 )
Advertising and marketing                          1,650        12,146        (10,496 )
Total operating expenses                     $   211,992     $ 363,617     $ (151,625 )

General and administrative expenses during the three-month period ended July 31, 2020 of $211,992 ($363,617- 2019) include management and consulting fees of $85,000 as compared to $277,000 in the comparative three months ended July 31, 2019. This decrease to management fees is a direct result of the departure of certain consultants during fiscal 2020, and the Company's determination not to renew certain contracts on their expiry. Expenditures of $1,650 during the three months ended July 31, 2020 (2019 - $12,146) on advertising and marketing reflect a reduction in costs paid to Yahoo as the Company has refocused its marketing efforts on its licensed Herbo enterprise software suite through a reseller agreement and curtailed its app marketing expenses during the current three-month period. During the current three months the Company recorded costs of revenue of $13,122 compared to $Nil in the prior comparative three-month period as we were able to expand our customer base for our licensed Herbo Enterprise Software. Legal, accounting and audit fees incurred in the three-month period ended July 31, 2020 of $30,131 have also decreased substantially as compared to $60,236 in the prior comparative period as the Company's legal fees with respect to certain ongoing litigation declined in the current period as legal actions are moving to settlement. The Company expended $36,469 on research, development and promotion in the current three months ended July 31, 2020 as we continued improvements to our licensed Herbo enterprise software as compared to $Nil in the same three months ended July 31, 2019. Office supplies and other general expenses increased period over period and totaled $45,177 (2020) and $13,130 (2019), respectively.


                                       7

--------------------------------------------------------------------------------

The Company reduced its operating expenses by $151,625 over the respective three-month periods ended July 31, 2020 and 2019.

The Company recorded interest expense of $64,401 and $62,816 in respect of certain convertible notes and other loan agreements, respectively during the three months ended July 31, 2020 and 2019. Interest income recorded in the three months ended July 31, 2020 and 2019 totaled $Nil and $3,000, respectively.

The net loss in the comparative three-month periods ended July 31, 2020 and 2019 totaled $258,966 and $423,433, respectively.

Comparison of the six months ended July 31, 2020 and 2019

The following summary of the Company's results of operations should be read in conjunction with the Company's unaudited consolidated financial statements for the six months ended July 31, 2020 and 2019:



                                                For the Six Months
                                                  Ended July 31,
                                                2020           2019
Revenue                                      $   32,259     $        -
Revenue, related parties                          5,394              -
Total revenue                                    37,653              -

Operating expenses:
Cost of revenue                                  26,644              -
Depreciation                                      1,548          2,211
Legal, accounting and audit fees                 65,237        137,950
Management and consulting fees                   80,000        568,000
Research, development, and promotion             71,521         19,764
Office supplies and other general expenses       94,173         61,956
Advertising and marketing                         3,240         27,903
Total operating expenses                        342,363        817,784

Net operating loss                             (304,710 )     (817,784 )

Other income (expenses)
Interest income                                       -          6,000
Interest expense                               (127,203 )     (123,104 )
Total other income (expense)                   (127,303 )     (117,104 )

Net loss                                     $ (431,913 )   $ (934,888 )



Revenue

During the six months ended July 31, 2020, the Company generated $37,653 in total revenue of which $5,394 was from contracts with related parties, as compared to $Nil in the six months ended July 31, 2019. Revenue recorded during the most recently completed six-month period relates directly to the licensing of the Herbo enterprise software to various customers. We entered into amendments to certain licensing and marketing agreements subsequent during fiscal 2019 which provide for fee-based income calculated retroactively between March and October 2018 as a result of certain beta trials with respect to the eXPOTM platform, as at July 31, 2020, the amounts generated from this agreement have not been received by the Company and therefore while revenue has been generated, no revenue has been recorded in our financial statements. We intend to record the revenue attributable to the Company of $28,431 upon receipt.


                                       8

--------------------------------------------------------------------------------

Cost of Revenue

Costs of revenue consist of the direct expenses incurred to generate revenue, including fees and commissions payable. Such costs are recorded as incurred. During the six months ended July 31, 2020 we incurred costs of $26,644 as compared to $Nil during the six months ended July 31, 2019. Current costs are related to sales of our licensed Herbo enterprise software. Our ongoing costs of revenue will consist consists primarily of fees and commissions paid in respect to the operation and installation of our Herbo enterprise software. In the case of revenue earned by our wholly owned subsidiary, when recorded, proceeds allocated to our revenue interest are net of associated costs.

General and Administrative Expenses



                                               For the Six Months
                                                 Ended July 31,
                                               2020          2019        Variances
Operating expenses:
Cost of revenue                              $  26,644     $       -     $   26,644
Depreciation                                     1,548         2,211           (663 )
Legal, accounting and audit fees                65,237       137,950        (72,713 )
Management and consulting fees                  80,000       568,000       (488,000 )
Research, development, and promotion            71,521        19,764         51,757
Office supplies and other general expenses      94,173        61,956        (32,217 )
Advertising and marketing                        3,240        27,903        (24,663 )
Total operating expenses                     $ 342,363     $ 817,784     $ (475,421 )

General and administrative expenses during the six-month period ended July 31, 2020 of $342,363 ($817,784 - 2019) include management and consulting fees of $80,000 as compared to $568,000 in the comparative six months ended July 31, 2019. This decrease to management fees is a result of a reduction in consulting fees during the current six-month period due to the departure of certain consultants and management and the Company's determination not to renew certain contracts on their expiry, as well as a credit related to certain prior accrued fees for consulting services in the amount of $90,000 which were forgiven in the current six months ended July 31, 2020. Expenditures of $3,240 during the three months ended July 31, 2020 (2019 - $27,903) on advertising and marketing reflect a reduction in costs paid to Yahoo as the Company has refocused its marketing efforts on its licensed Herbo enterprise software suite through a reseller agreement and curtailed its app marketing expenses during the current six-month period. During the current six months the Company recorded costs of revenue of $26,644 compared to $Nil in the prior comparative six-month period as we were able to expand our customer base for our licensed Herbo Enterprise Software.

Legal, accounting and audit fees incurred in the six month period ended July 31, 2020 of $65,237 have also decreased substantially as compared to $137,950 in the prior comparative period as the Company's legal fees with respect to certain ongoing litigation declined in the current period as legal actions are moving to settlement. The Company expended $71,521 on research, development and promotion in the current six months ended July 31, 2020 as we continued improvements to our licensed Herbo enterprise software as compared to $19,764 in the same six months ended July 31, 2019. Office supplies and other general expenses increased period over period and totaled $94,1736 (2020) and $61,956 (2019), respectively.

The Company reduced its operating expenses by $475,421 over the respective six-month periods ended July 31, 2020 and 2019.

The Company recorded interest expense of $127,203 and $123,104 in respect of certain convertible notes and other loan agreements, respectively during the six months ended July 31, 2020 and 2019. Interest income recorded in the six months ended July 31, 2020 and 2019 totaled $Nil and $6,000, respectively.

The net loss in the comparative six-month periods ended July 31, 2020 and 2019 totaled $431,913 and $934,888, respectively.


                                       9

--------------------------------------------------------------------------------

Plan of Operation

The Company changed the focus of its business at the close of fiscal 2016 to operate in the ecofriendly technology sector using social media sites and offering apps to generate advertising revenues and download fees. During fiscal 2017 the Company laid the groundwork for income generation from these services by investing in ongoing development of its applications, websites and visibility in both the local and global market. The Company has invested heavily in advertising and research and development to allow its applications and ecommerce website visibility on a global stage. During fiscal 2018 we further added to our business portfolio with the acquisition of Ga-Du corporation and the entry into a licensing and marketing agreement that should see the Company generating revenues in fiscal 2019. During fiscal 2019, the Company licensed the Herbo Enterprise Software suite and completed certain customization efforts, which has allowed the Company to commence generating revenue by way of sales of software licenses during fiscal 2020 and during the current six months ended July 31, 2020. The Company's need for ongoing capital by way of loans, sale of equity and/or convertible notes is expected to continue during the current fiscal year until we can establish substantive revenues from operations. We have also had to rely heavily on loans from related parties in our most recently completed fiscal year as we work to have our shares returned for quotation to the OTCMarkets. There are no assurances additional capital will be available to the Company on acceptable terms or that this equity line will be available to us when needed.

Future funding could result in potentially dilutive issuances of equity securities, the incurrence of debt, contingent liabilities and/or amortization expenses related to goodwill and other intangible assets, which could materially adversely affect the Company's business, results of operations and financial condition. Any future funding might require the Company to obtain additional equity or debt financing, which might not be available on terms favorable to the Company, or at all, and such financing, if available, might be dilutive.

Going Concern

These unaudited condensed consolidated financial statements have been prepared on a going concern basis, which implies that the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The Company has not generated significant revenues to date and has never paid any dividends and is unlikely to pay dividends or generate significant earnings in the immediate or foreseeable future. As at July 31, 2020, the Company had a working capital deficit of $11,678,088 and an accumulated deficit of $73,479,995. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders, the ability to raise equity or debt financing, and the attainment of profitable operations from the Company's future business. These factors raise substantial doubt regarding the Company's ability to continue as a going concern.

The recent COVID-19 pandemic could have an adverse impact on the Company going forward. COVID-19 has caused significant disruptions to the global financial markets, which may severely impact the Company's ability to raise additional capital and to pursue certain planned business activities. The Company may be required to cease operations if it is unable to finance its' operations. The full impact of the COVID-19 outbreak continues to evolve as of the date of this report and is highly uncertain and subject to change. Management is actively monitoring the situation but given the daily evolution of the COVID-19 outbreak, the Company is not able to estimate the effects of the COVID-19 outbreak on its operations or financial condition in the next 12 months. There are no assurances that the Company will be able to meet its obligations, raise funds or continue to implement its planned business objectives to obtain profitable operations.

The unaudited consolidated financial statements reflect all adjustments consisting of normal recurring adjustments, which, in the opinion of management, are necessary for a fair presentation of the results for the periods shown. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the Company cannot continue in existence.




                                       10

--------------------------------------------------------------------------------

Liquidity and Capital Resources

As of July 31, 2020, the Company had total current assets of $57,901, and total current liabilities of $11,735,989 as compared to $59,310 in current assets and $11,307,033 in total current liabilities at the fiscal year ended January 31, 2020. The Company has limited financial resources available outside loans from its officers and directors and funds it has obtained through use of convertible notes and loans from related parties. We have recently commenced generating revenue from the licensing of our Herbo Enterprise Software, however, these revenues are not yet sufficient to meet our ongoing operational overhead. While the Company entered into an Equity Purchase Agreement to sell up to 10,000,000 shares of our common stock (Ref: Note 11(b)) to the financial statements contained herein) we have been unable to obtain any funding under this agreement in the most recently completed fiscal year. There can be no guarantee the Company will receive proceeds from loans, related party advances or convertible notes sufficient to meet its ongoing operational overheads. While we have generated modest revenue in fiscal 2020 and in the current quarter from the Herbo Enterprise Software, as well as $28,431 during fiscal 2019 relative to Ga-Du's agreements with AFN, which will be recorded when received from our licensing partner, we do not yet have resources to meet our operational shortfalls. Without realization of additional capital, it would be unlikely for the Company to continue as a going concern. As noted, additional working capital may be sought through additional debt or equity private placements, additional notes payable to banks or related parties (officers, directors or stockholders), or from other available funding sources at market rates of interest, or a combination of these. The ability to raise necessary financing will depend on many factors, including the nature and prospects of any business to be acquired and the economic and market conditions prevailing at the time financing is sought. During the most recently completed fiscal year management has obtained additional funding with success, however there is no guarantee we will be able to continue to obtain financing if and when required. The current economic downturn and ongoing impact of COVID-19 may make it difficult to find new capital sources for the Company should they be required.

Cash flows from operating activities

During the six months ended July 31, 2020 and 2019 the Company used $232,688 and $352,856 of cash for operating activities respectively. The decrease in cash used in operating activities period over period is attributed to a reduction to the net loss reported in the six months ended July 31, 2020 as compared to the same six months in 2019. Current period results include an increase to related party payables of $126,514 as compared to $265,986 in the same six-month period in 2019, and an increase to accounts payable of $72,046 in the current six months as compared to an increase of $319,835 in the period ended July 31, 2019. This is primarily due to the settlement of certain prior accrued consulting fees at a discount to the originally recorded contract value. The Company recorded an increase to prepaid expenses of $6,000 during the six months ended July 31, 2019, with no comparable results during the current six months ended July 31, 2020. Finally, we recorded a decrease to accounts receivable in the current six months ended July 31, 2020 of $4,511 and an increase to related party receivables of $5,394 with no comparable results during the six months ended July 31, 2019.

Cash flows from investing activities

During the three months ended July 31, 2020 and 2019, the Company used no cash for investing activities.

Cash flows from financing activities

During the six months ended July 31, 2020 and 2019 the Company repaid $5,000 and $Nil of notes payable. Further during the current six months ended July 31, 2020 the Company received related party loans of $235,396 as compared to $353,618 in the prior comparative six months ended July 31, 2019.

Future Financings

We anticipate continuing to rely on related party and third-party loans and equity sales of our common shares and/or shares for services rendered in order to continue to fund our business operations in the event of ongoing operational shortfalls. Issuances of additional shares will result in dilution to our existing shareholders. There is no assurance that we will achieve any of additional sales of our equity securities or arrange for debt or other financing to fund our research and development activities.

Contractual Obligations

The Company is a smaller reporting Company as defined by Rule 12b-2 of the Securities Act of 1934 and we are not required to provide the information under this item.

Off-Balance Sheet Arrangements

The Company has no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on the Company's financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to stockholders.

Critical Accounting Policies

The preparation of our condensed consolidated financial statements and notes thereto requires management to make estimates and assumptions that affect the amounts and disclosures reported within those financial statements. On an ongoing basis, management evaluates its estimates, including those related to revenue recognition, contingencies, litigation and income taxes. Management bases its estimates and judgments on historical experiences and on various other factors believed to be reasonable under the circumstances. Actual results under circumstances and conditions different than those assumed could result in differences from the estimated amounts in the financial statements. There have been no material changes to these policies during the six months ended July 31, 2020. Refer to Note 2 to our unaudited condensed consolidated financial statements contained herein.


                                       11

--------------------------------------------------------------------------------

Recently issued accounting pronouncements

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements will have a material impact on its financial condition or the results of its operations.

© Edgar Online, source Glimpses